The Knowledge Group
The Knowledge Group

Sheila Swaroop, Partner, Knobbe Martens Olson & Bear LLP to Speak at KC’s Event

New York, NY, August 27, 2015 --( The Knowledge Group/The Knowledge Congress Live Webcast Series, the leading producer of regulatory focused webcasts, has announced today Sheila Swaroop, Partner, Knobbe Martens Olson & Bear LLP will speak at the Knowledge Congress’ webcast entitled “BPCIA Litigation: Latest Developments for 2015 and Beyond Live Webcast” This event is scheduled for Tuesday, September 1, 2015 @ 12:00 PM to 2:00 PM (ET).

For further details, please visit:

About Sheila Swaroop

Sheila Swaroop is a partner at Knobbe Martens Olson & Bear LLP. She is a registered patent attorney and holds an undergraduate degree in molecular biology from Harvard University and a J.D. from UC Berkeley. Ms. Swaroop is experienced with advising clients on intellectual property strategies for biosimilars, litigating intellectual property disputes in district court and the International Trade Commission, and conducting Patent Office proceedings.

About Knobbe Martens Olson & Bear LLP

Knobbe Martens has one of the largest and most experienced biotechnology groups in IP law, with more than 75 attorneys and scientists representing clients in all stages of their business and technology development. It maintains a talented litigation group adept in all aspects of biotechnology IP law. The extensive Hatch-Waxman litigation practice combined with its deep technical expertise in biotechnology uniquely position Knobbe Martens to develop and implement effective IP strategies for biosimilars.

KC Event Synopsis:

Five years after the Biologics Price Competition and Innovation Act (BPCIA) has been passed into law, litigation related to the patent resolution procedure for biosimilars has begun to rise.

In a two-hour live Webcast, a panel of thought leaders and practitioners assembled by The Knowledge Group will offer an in-depth discussion of the significant and latest issues surrounding BPCIA. Speakers will examine the new BPCIA legal framework created to resolve patent disputes between biosimilar applicants and patent holders as well the updates to recent biosimilar-related cases.

Key issues that will be covered in this course are:
- Biologics Price Competition and Innovation Act (BPCIA) – An Overview
- Latest Framework for Biosimilar Patent-Related Dispute Resolution
- Recent Developments in BPCIA Litigation such as:
- Implications of Amgen v. Sandoz of patent exchange and notice of commercial marketing
- Alternatives for patent resolution

About The Knowledge Group/The Knowledge Congress Live Webcast Series

The Knowledge Congress is a series of live webcasts produced by The Knowledge Group, which examine trends, regulatory, and technology changes across a variety of industries. For further details, please visit:
The Knowledge Group
Thomas LaPointe, Jr., Executive Director
Therese Lumbao, Director
Account Management & Member Services